ID: ALA5186358

Max Phase: Preclinical

Molecular Formula: C21H20N5Na2O9PS

Molecular Weight: 551.47

Associated Items:

Representations

Canonical SMILES:  O=c1ccn([C@@H]2O[C@H](COCc3cn(C(c4csc5ccccc45)P(=O)([O-])[O-])nn3)[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+]

Standard InChI:  InChI=1S/C21H22N5O9PS.2Na/c27-16-5-6-25(21(30)22-16)19-18(29)17(28)14(35-19)9-34-8-11-7-26(24-23-11)20(36(31,32)33)13-10-37-15-4-2-1-3-12(13)15;;/h1-7,10,14,17-20,28-29H,8-9H2,(H,22,27,30)(H2,31,32,33);;/q;2*+1/p-2/t14-,17-,18-,19-,20?;;/m1../s1

Standard InChI Key:  IBMWEUCBCFSMIQ-HKGOZWDTSA-L

Associated Targets(Human)

Beta-galactoside alpha-2,6-sialyltransferase 1 179 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 551.47Molecular Weight (Monoisotopic): 551.0876AlogP: -0.10#Rotatable Bonds: 8
Polar Surface Area: 202.02Molecular Species: ACIDHBA: 12HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 1.33CX Basic pKa: CX LogP: -0.58CX LogD: -2.82
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.18Np Likeness Score: -0.11

References

1. Dobie C, Montgomery AP, Szabo R, Yu H, Skropeta D..  (2021)  Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors.,  12  (10.0): [PMID:34778769] [10.1039/D1MD00079A]
2. Dobie C, Montgomery AP, Szabo R, Yu H, Skropeta D..  (2021)  Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors.,  12  (10.0): [PMID:34778769] [10.1039/D1MD00079A]

Source